LDX
LUMOS DIAGNOSTICS HOLDINGS LIMITED
$0.0710
▲ +1.43%
Market cap
$70M
Turnover
$11,323
Last price
$0.0710
Day change
+1.43%
Announcements
15
Range, past year
Open 0.190 · Low 0.024 · Now 0.071 · High 0.335
Open LDX in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
LDX momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
35/100
Wyckoff phase
Accumulation6d
Trend stage
Neutral
1 Day
+1.4%
1 Week
-2.7%
1 Month
-20.2%
1 Year
-64.5%
RSI
45
Avg daily range
9.3%
LUMOS DIAGNOSTICS HOLDINGS LIMITED scores 35 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -52.5%
- High volatility (ATR 9.3%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
LDX announcements
Recent price-sensitive releases.
- 2026-11-09 Lumos Expands FebriDx Adoption Across WellStreet Locations Progress Report
- 2026-10-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Web Cast | Commitments Test Entity - First Quarter Cashflow Report
- 2026-09-15 FebriDx Commercial Traction Continues Across US Accounts Progress Report
- 2026-08-26 FY26 Full Year Results Announcement Preliminary Final Report | Periodic Reports - Other
- 2026-08-26 FY26 Appendix 4E Preliminary Final Report
- 2026-08-04 Lumos Receives FebriDx Order from PHASE Scientific Progress Report
- 2026-07-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Web Cast | Commitments Test Entity - Fourth Quarter Cashflow Report
More Health Care stocks
Most traded in the same sector.